Authors:
Niranjan, A
Moriuchi, S
Lunsford, LD
Kondziolka, D
Flickinger, JC
Fellows, W
Rajendiran, S
Tamura, M
Cohen, JB
Glorioso, JC
Citation: A. Niranjan et al., Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration, MOL THER, 2(2), 2000, pp. 114-120
Authors:
Mito, T
Maekawa, R
Iwamoto, A
Imagawa, S
Takahata, K
Yamada, S
Yanagi, N
Nishimura, A
Tamura, H
Chikaraishi, H
Hamaguchi, S
Baba, T
Moriuchi, S
Oba, K
Sekiguchi, H
Otake, F
Satow, T
Nakamura, Y
Satoh, S
Motojima, O
Citation: T. Mito et al., Performance of the LHD cryogenic system during cooling and excitation tests, IEEE APPL S, 10(1), 2000, pp. 1507-1510
Authors:
Moriuchi, S
Krisky, DM
Marconi, PC
Tamura, M
Shimizu, K
Yoshimine, T
Cohen, JB
Glorioso, JC
Citation: S. Moriuchi et al., HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma, GENE THER, 7(17), 2000, pp. 1483-1490
Authors:
Motojima, O
Akaishi, K
Chikaraishi, H
Funaba, H
Hamaguchi, S
Imagawa, S
Inagaki, S
Inoue, I
Iwamoto, A
Kitagawa, S
Komori, A
Kubota, Y
Maekawa, R
Masuzaki, S
Mito, T
Miyazawa, J
Morisaki, T
Murai, K
Muroga, T
Nagasaka, T
Nakamura, Y
Nishimura, A
Nishimura, K
Noda, N
Ohyabu, N
Sagara, A
Sakakibara, S
Sakamoto, R
Satoh, S
Satow, T
Shoji, M
Suzuki, H
Takahata, K
Tamura, H
Watanabe, KY
Yamada, H
Yamada, S
Yamaguchi, S
Yamazaki, K
Yanagi, N
Baba, T
Hayashi, H
Iima, M
Inoue, T
Kato, S
Kato, T
Kondo, T
Moriuchi, S
Ogawa, H
Ohtake, I
Ooba, K
Sekiguchi, H
Suzuki, N
Takami, S
Taniguchi, Y
Tsuzuki, T
Yamamoto, N
Yasui, E
Yonezu, H
Fujiwara, M
Iiyoshi, A
Citation: O. Motojima et al., Progress summary of LHD engineering design and construction, NUCL FUSION, 40(3Y), 2000, pp. 599-609
Citation: M. Tsutsumi et al., Development of a detector for measuring effective dose (equivalent) for external photon exposures in natural environment, J NUC SCI T, 37(3), 2000, pp. 300-306
Authors:
Mito, T
Maekawa, R
Yamada, S
Nishimura, A
Takahata, K
Iwamoto, A
Imagawa, S
Watanabe, K
Yanagi, N
Tamura, H
Baba, T
Moriuchi, S
Oba, K
Sekiguchi, H
Ohtake, I
Satow, T
Satoh, S
Motojima, O
Citation: T. Mito et al., First cool-down performance of the LHD, IEEE APPL S, 9(2), 1999, pp. 640-643
Authors:
Ohtomo, T
Kawata, H
Sekimori, Y
Shimizu, K
Kishima, H
Moriuchi, S
Miyao, Y
Akamatsu, KI
Tsuchiya, M
Citation: T. Ohtomo et al., A humanized single-chain Fv fragment with high targeting potential againsthuman malignant gliomas, ANTICANC R, 18(6A), 1998, pp. 4311-4315
Authors:
Moriuchi, S
Oligino, T
Krisky, D
Marconi, P
Fink, D
Cohen, J
Glorioso, JC
Citation: S. Moriuchi et al., Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase, CANCER RES, 58(24), 1998, pp. 5731-5737
Authors:
Suzuki, T
Piche, A
Kasono, K
Xiang, JL
Gomez-Navarro, J
Moriuchi, S
Krisky, DM
Oligino, T
Glorioso, JC
Curiel, TJ
Curiel, DT
Citation: T. Suzuki et al., Efficient gene delivery into Epstein-Barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy, BIOC BIOP R, 252(3), 1998, pp. 686-690